MedPath
HSA Approval

EFAVIRENZ SANDOZ FILM COATED TABLET 600MG

SIN15719P

EFAVIRENZ SANDOZ FILM COATED TABLET 600MG

EFAVIRENZ SANDOZ FILM COATED TABLET 600MG

June 18, 2019

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J05AG03

efavirenz

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Sandoz Private Limited

Active Ingredients

Efavirenz

600mg

Efavirenz

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EFAVIRENZ SANDOZ FILM COATED TABLET 600MG - HSA Approval | MedPath